title: Correlation between distal nephron enzyme activity, structure and function in rats during lithium and lithium plus neuroleptic treatment.
abstract: The histochemical activities of nonspecific acid and alkaline phosphatases, NADH- and NADPH-tetrazolium reductases, alpha-glycerophosphate dehydrogenase, succinate dehydrogenase, isocitrate dehydrogenase, lactate dehydrogenase and glucose-6-phosphate dehydrogenase were investigated in kidneys from rats treated with lithium and lithium plus neuroleptics. During the first 8 weeks of lithium treatment the activity of NADH-tetrazolium reductase, succinate dehydrogenase and alpha-glycerophosphate dehydrogenase activity in the collecting ducts increased. The other enzymes did not change. After 8 weeks of treatment no further changes in enzyme activity occurred. Withdrawal of lithium caused normalization of enzyme activity after 8 weeks. A decrease in concentration ability was found in parallel with the increase in enzyme activities (p less than 0.001). The changes in enzyme activity were not significantly correlated to morphological changes in the collecting ducts. Treatment with neuroleptics alone caused no change in enzyme activity. During combined lithium plus neuroleptic treatment the enzyme activities changed in a similar way as during lithium therapy, but the changes were less pronounced. In parallel, a less pronounced decrease in concentration ability was found during this treatment.
authors.forename: T
authors.initials: T
authors.lastname: Nørgaard
authors.forename: P
authors.initials: P
authors.lastname: Faarup
authors.forename: B B
authors.initials: BB
authors.lastname: Hansen
authors.forename: A R
authors.initials: AR
authors.lastname: Kristensen
authors.forename: S
authors.initials: S
authors.lastname: Christensen
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D005993:Glycerolphosphate Dehydrogenase / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D006651:Histocytochemistry; D007671:Kidney Concentrating Ability / Q000187:drug effects; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D009246:NADH Tetrazolium Reductase / Q000378:metabolism; D009399:Nephrons / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D010546:Perphenazine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013385:Succinate Dehydrogenase / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D008094:Lithium; D005993:Glycerolphosphate Dehydrogenase; D013385:Succinate Dehydrogenase; D009246:NADH Tetrazolium Reductase; D010546:Perphenazine; D006220:Haloperidol; D002746:Chlorpromazine